Status:
COMPLETED
Incentives to Promote Sustained Linkage to HIV Care
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Wits Reproductive Health and HIV Institute
Bill and Melinda Gates Foundation
Conditions:
Human Immunodeficiency Virus
HIV/AIDS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to test if small incentives promote linkage to care and 6-month viral suppression among individuals recently tested for HIV at selected sites within Johannesburg, South Africa. Individ...
Detailed Description
This study is in collaboration with Ezintsha, a sub-division of Wits Reproductive Health and HIV Institute (WRHI) in South Africa. This study will leverage on the existing research infrastructure of E...
Eligibility Criteria
Inclusion
- Reported HIV positive
- Have a personal and/or valid phone number, that will remain active for 6 months
- Have a phone with WhatsApp, or text message feature
- Understand the Informed Consent form
Exclusion
- Unwilling to provide informed consent
- Any condition which would make the participant unsuitable or unsafe for enrollment, i.e. being unable to see or read by forgetting to bring reading glasses, being intoxicated or acute sickness
Key Trial Info
Start Date :
July 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT04431154
Start Date
July 20 2020
End Date
July 30 2021
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ezintsha Clinical Research Center
Johannesburg, Gauteng, South Africa, 2193